Financial reports
10-Q
2024 Q1
Quarterly report
9 May 24
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
15 Mar 22
Current reports
8-K
Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
9 May 24
8-K
Entry into a Material Definitive Agreement
10 Apr 24
8-K
Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
12 Mar 24
8-K
Rallybio Announces Portfolio Prioritization and Provides Corporate Update
6 Feb 24
8-K
Regulation FD Disclosure
20 Dec 23
8-K
Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
9 Nov 23
8-K
Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
8 Aug 23
8-K
Departure of Directors or Certain Officers
29 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
22 May 23
8-K
Rallybio Reports First Quarter 2023 Financial Results
9 May 23
Registration and prospectus
S-3
Shelf registration
10 May 24
D
$6.60 mm in equity, sold $6.60 mm, 1 investor
22 Apr 24
S-8
Registration of securities for employees
13 Mar 24
424B3
Prospectus supplement
12 May 23
S-8
Registration of securities for employees
10 May 23
S-3
Shelf registration
9 May 23
424B5
Prospectus supplement for primary offering
14 Nov 22
424B5
Prospectus supplement for primary offering
10 Nov 22
424B5
Prospectus supplement for primary offering
15 Aug 22
S-3
Shelf registration
8 Aug 22
Proxies
DEF 14A
Definitive proxy
11 Apr 24
DEF 14A
Definitive proxy
10 Apr 23
DEF 14A
Definitive proxy
25 Apr 22
Other
EFFECT
Notice of effectiveness
15 May 23
UPLOAD
Letter from SEC
11 May 23
CORRESP
Correspondence with SEC
11 May 23
EFFECT
Notice of effectiveness
16 Aug 22
CORRESP
Correspondence with SEC
11 Aug 22
UPLOAD
Letter from SEC
11 Aug 22
CERT
Certification of approval for exchange listing
29 Jul 21
EFFECT
Notice of effectiveness
29 Jul 21
SEC STAFF
SEC staff action: Order
28 Jul 21
CORRESP
Correspondence with SEC
26 Jul 21
Ownership
4
Stephen Uden
16 Feb 24
4
MARTIN MACKAY
16 Feb 24
4
Jonathan I Lieber
16 Feb 24
4
Steven Ryder
16 Feb 24
SC 13G/A
VIKING GLOBAL INVESTORS LP
14 Feb 24
SC 13D/A
Pivotal bioVenture Partners Fund I, L.P.
12 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
KUSH PARMAR
4 Jan 24
4
RONALD HUNT
4 Jan 24
SC 13G/A
Novo Holdings A/S
2 Jan 24